Telehealth Counseling and Nicotine Replacement Products Urged as Standard in Oncology Care, Study Says

Telehealth-based counseling and nicotine replacement therapy should be integrated into routine cancer care to improve patient outcomes, according to a recent analysis published in the JAMA Oncology. The recommendation follows evidence that tobacco use during cancer treatment is linked to higher recurrence rates and poorer survival, with telehealth offering a scalable solution to address this gap.

Research Highlights Benefits of Telehealth in Oncology

A 2023 study led by researchers at the University of California, San Francisco, found that cancer patients who received telehealth counseling to quit smoking were 40% more likely to remain tobacco-free at 12 months compared to those who received standard care. The study, which tracked 1,200 participants across 15 U.S. cancer centers, emphasized the role of remote support in overcoming barriers like transportation and time constraints.

“Telehealth removes logistical hurdles and provides continuous support, which is critical during treatment,” said Dr. Emily Carter, a co-author of the study and a medical oncologist at UCSF. “This isn’t just about convenience—it’s about saving lives.”

Nicotine Replacement Therapy Seen as Complementary Tool

Nicotine replacement products, such as patches and gum, are increasingly being paired with behavioral counseling to address tobacco dependence. A 2022 review in Cancer Epidemiology, Biomarkers & Prevention found that combining pharmacotherapy with telehealth support doubled the quit rates among cancer patients compared to pharmacotherapy alone.

The American Cancer Society (ACS) has endorsed this approach, stating that “tobacco cessation is a vital component of cancer care, and telehealth offers a practical way to deliver these interventions at scale.” The ACS also noted that 1 in 5 cancer patients continues to use tobacco, despite the known risks.

Challenges in Implementation

Despite the evidence, widespread adoption faces hurdles. A 2023 survey by the National Coalition for Cancer Survivorship found that only 30% of oncology clinics offer structured tobacco cessation programs. Barriers include reimbursement issues, lack of training, and limited access to telehealth infrastructure in rural areas.

“Insurance coverage often doesn’t reimburse for telehealth counseling, and many providers aren’t equipped to address tobacco use as part of cancer care,” said Dr. Michael Torres, a public health researcher at the University of Michigan. “This needs to change.”

Policy and Clinical Guidelines Evolving

The National Comprehensive Cancer Network (NCCN) updated its clinical guidelines in 2024 to include telehealth-based tobacco cessation as a recommended intervention. The guidelines also advise oncologists to screen patients for tobacco use at every visit and refer them to cessation programs.

Legislative efforts are also gaining momentum. The 2024 Cancer Care Access Act, introduced in the U.S. Senate, aims to expand Medicare coverage for telehealth counseling and nicotine replacement products for cancer patients. If passed, the bill could significantly increase access to these services.

What This Means for Patients

For cancer patients, the integration of telehealth and nicotine replacement therapy represents a shift toward holistic care. Quitting tobacco can improve treatment outcomes, reduce complications, and enhance quality of life. However, experts stress that success depends on consistent support and addressing systemic barriers.

“This is a win for patients and providers alike,” said Dr. Sarah Lin, an oncologist at the Mayo Clinic. “By making these tools available, we’re not just treating cancer—we’re addressing the whole person.”